TROW vs TWST · P/E 12, rev $3.76B vs rev $332.8M
T. Rowe Price Group Inc (TROW) versus Twist Bioscience Corp (TWST) — a side-by-side from cached financials, not a winner call.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
TROW currently screens at market cap $23.17B and trailing P/E 11.6. TWST currently screens at market cap $5.16B.
Not investment advice. Open the TROW and TWST stock pages for the full models.
Not investment advice.